On July 16, 2015, the Can Tho Journal of Medicine and Pharmacy was officially granted an international standard serial number (ISSN 2354-1210).
Since April 2016, the Journal has been recognized by the Medical

Professorship Council of Vietnam and included in the list of scientific medical journals eligible for academic credit (0–0.5 points per published article).

In 2020, the Journal was approved by the Pharmacy Professorship Council of Vietnam as an eligible journal for academic credit (0–0.5 points per published article).

Since December 2022, the Journal has been a member of the Crossref system. From January 2023, it has implemented a double-blind online peer-review process, aiming to enhance transparency, reliability, and scientific quality of published research.

Aims, objectives, and Scope

Aims and Objectives

The Can Tho Journal of Medicine and Pharmacy aims to disseminate scientific research findings; promote academic exchange and experience sharing; support continuous learning; and provide updated scientific knowledge in the fields of medicine, biology, and pharmacy at both national and international levels.

Scope

The Can Tho Journal of Medicine and Pharmacy publishes original research articles, review papers, and case reports in the field of health sciences, with a particular focus on the following areas:

• Medicine: Clinical and paraclinical research; disease prevention, diagnosis, and treatment; internal medicine, surgery, pediatrics, obstetrics and gynecology, traditional medicine, family medicine, and related clinical specialties.
• Pharmacy: Pharmacognosy, pharmacology, pharmaceutical chemistry, pharmaceutics, drug quality control, clinical pharmacy, and rational, safe, and effective use of medicines.
• Dentistry and Maxillofacial Sciences: Preventive dentistry, diagnosis and treatment of oral and maxillofacial diseases, oral and maxillofacial surgery, dental materials, and community oral health.
• Public Health: Epidemiology, environmental health, community nutrition, health systems management, health policy, primary health care, and health promotion.
• Nursing: Clinical nursing practice, nursing management, patient safety, community nursing, and nursing education.
• Biomedical Sciences: Molecular biology, cell biology, immunology, microbiology, biochemistry, medical biotechnology, and preclinical research supporting medicine and pharmacy.

The Journal prioritizes studies with strong scientific merit and practical relevance, encourages interdisciplinary research, and aims to contribute to the advancement of healthcare practice, disease prevention, and the improvement of population health.

Publication Frequency

The Can Tho Journal of Medicine and Pharmacy publishes 12 issues per year, including two English-language issues released in June and December. Manuscripts are published only after receiving favorable evaluations from at least two independent reviewers and final approval by the Editor-in-Chief.

In addition to regular issues, the Journal publishes special issues dedicated to scientific conferences and workshops. The peer-review and publication processes for special issues follow the same standards as regular issues, including double-blind peer review, and are conducted entirely online via the Journal’s website: https://tapchi.ctump.edu.vn

Open Access Policy

The Can Tho Journal of Medicine and Pharmacy operates under a full open access policy, providing readers with free and immediate access to all published articles. This policy aims to broaden access to high-quality research and promote knowledge exchange.

All articles are published online in full text and made freely available on the Journal’s website (https://tapchi.ctump.edu.vn). Readers are permitted to read, download, copy, distribute, print, search, or link to the full texts of articles without prior registration, subscription fees, or permission from the Editorial Board or authors.

Copyright and Licensing

All articles published in the Can Tho Journal of Medicine and Pharmacy are licensed under the Creative Commons Attribution–NonCommercial 4.0 International License (CC BY-NC 4.0).

Readers are allowed to copy, distribute, transmit, and adapt the work, provided that proper attribution is given to the original authors and the Journal. Authors retain the copyright of their articles while granting the Journal the right of first publication.

Publication Ethics

The Can Tho Journal of Medicine and Pharmacy is committed to upholding publication ethics in accordance with the guidelines and standards of the Committee on Publication Ethics (COPE), including COPE’s Core Practices, Best Practice Guidelines for Journal Editors, and Guidelines on Good Publication Practice.

For manuscripts submitted as Clinical Case Reports, authors are required to obtain written informed consent for publication from the patient or the patient’s legal guardian, permitting the publication of clinical information and any associated images in both print and online formats. The manuscript must include a statement confirming that informed consent for publication has been obtained. The Editorial Office reserves the right to request a copy of the informed consent document during the peer-review and editorial assessment process. The Journal recommends that Clinical Case Reports be prepared in accordance with the CARE (CAse REport) Guidelines to enhance transparency, completeness, and compliance with international reporting standards. Authors are encouraged to submit a completed CARE checklist together with the manuscript.

Duties of Editors

• Publication Decisions: The Editorial Board holds full and independent responsibility for decisions regarding manuscript acceptance and publication, in compliance with journal policies and applicable regulations.
• Peer Review Management: Editorial Board members ensure fairness, impartiality, and timeliness in the peer-review process. Each manuscript is reviewed by at least two independent external experts with appropriate expertise.
• Fairness: Manuscripts are evaluated solely on scientific merit. Transparent editorial mechanisms are maintained for all decisions.
• Confidentiality: Editorial Board members must maintain confidentiality regarding submitted manuscripts and reviewer identities.
• Conflicts of Interest: Editorial Board members must recuse themselves from handling manuscripts in which they have conflicts of interest, including authorship, institutional affiliation, or financial interests.

Duties of Reviewers

Reviewers support editorial decision-making and contribute to improving manuscript quality. Reviewers who feel unqualified or unable to conduct a review must promptly decline the invitation.

• Confidentiality: Manuscripts under review are treated as confidential documents.
• Ethical Vigilance: Reviewers should report any ethical concerns, including plagiarism or substantial overlap with published works.
• Objectivity: Reviews must be conducted objectively, without personal bias. Self-citation requests must be scientifically justified.

Duties of Authors

• Authorship: Only individuals who have made significant contributions qualify as authors.
• Originality and Plagiarism: Manuscripts must be original, and all sources must be properly cited.
• Data Access and Retention: Authors must present accurate data and retain research data for a reasonable period after publication.
• Multiple Publications: Authors may not submit the same research to more than one journal.
• Conflicts of Interest: All potential conflicts of interest and sources of financial support must be clearly disclosed.
• Post-publication Corrections: Authors must promptly notify the Editorial Board of any significant errors discovered after publication.

Archiving Policy

Can Tho Journal of Medicine and Pharmacy is committed to ensuring the long-term preservation and accessibility of all published scholarly content. The journal’s articles are archived and made accessible through multiple systems to guarantee the integrity, discoverability, and persistent access to published research.

Author Self-Archiving

The journal permits authors to self-archive the final published version of their article (publisher’s PDF) immediately after publication on the journal’s official website.

Authors may deposit their articles in:

• Their personal websites;
• Institutional repositories maintained by their affiliated institutions on non-profit servers.

When self-archiving their articles, authors must:

• Clearly indicate the original source of publication in the Can Tho Journal of Medicine and Pharmacy;
• Provide a link to the journal’s website or to the article through its Digital Object Identifier (DOI).

Depositing articles in public disciplinary repositories or commercial repositories requires prior permission from the journal.

Indexing and Archiving Systems

The journal’s content is indexed and archived in several academic databases to enhance the visibility and accessibility of published research, including:

• Google Scholar
• Vietnam Journals Online (VOJL)

In addition, all published articles are assigned a Digital Object Identifier (DOI), which provides a unique and persistent identifier for each article. The DOI system ensures reliable long-term access to scholarly content even if the journal’s website address or storage location changes.

Commitment to Digital Preservation

The journal implements technical and administrative measures to ensure the long-term preservation and accessibility of its scholarly content. Archiving and identification systems are maintained to safeguard the integrity and retrievability of published research over time.

Policy on the Use of Artificial Intelligence (AI) and Publishing Support Technologies

• Transparent Disclosure: Authors must clearly disclose any use of AI tools or software (e.g., ChatGPT, Grammarly, QuillBot, MidJourney), including tool name, version, provider, purpose, and scope of use.
• Author Responsibility: AI tools may not be listed as authors. Authors bear full responsibility for the scientific content, accuracy, originality, and integrity of the manuscript.
• Limitations of Use: AI tools must not replace scientific reasoning, data analysis, or independent validation. The use of AI for handling sensitive or unpublished data is strictly prohibited.
• Editorial and Review Process: Editors and reviewers are not permitted to use AI tools to generate reviews, editorial comments, or publication decisions.
• Handling Violations: Failure to disclose AI use or dishonest disclosure constitutes a breach of publication ethics and may result in rejection or retraction.
• Policy Updates: This policy will be periodically reviewed to align with technological advancements and international standards.

Privacy and Confidentiality Commitment

The Journal is committed to complying with all applicable laws and regulations regarding personal data protection. Information provided by users (authors, readers, editors, and reviewers) through the online submission system is used solely for stated purposes and will not be shared with third parties.

Peer Review Process

The Can Tho Journal of Medicine and Pharmacy applies a double-blind peer-review process in accordance with international standards. The identities of reviewers are not disclosed to authors, and vice versa. The average time from submission to publication ranges from 3 to 6 months.

All manuscript submission and peer-review procedures are conducted entirely online via the Journal’s website at https://tapchi.ctump.edu.vn and include the following stages:

Manuscript Submission

Authors submit their manuscripts through the Journal’s online submission system at https://tapchi.ctump.edu.vn. Detailed instructions on author registration, manuscript submission, and manuscript preparation are available on the Journal’s website.

Preliminary screening and plagiarism check

Upon successful submission, all manuscripts are checked for similarity using plagiarism detection systems. The Editorial Office then conducts an initial screening to assess compliance with the Journal’s formatting and content requirements, adherence to the Author Guidelines, and scientific relevance.

Authors will receive one of the following notifications via email:

• The manuscript complies with submission requirements and is awaiting fee payment
• The manuscript requires revision and resubmission
• The manuscript is rejected

Manuscripts that pass the initial screening will receive an email invitation to complete the submission fee payment. After payment is confirmed, the Editorial Board assigns the manuscript to the Head of the relevant Specialty Section, who will invite two qualified reviewers with appropriate expertise.

The time from manuscript receipt to reviewer invitation typically ranges from 1 to 3 weeks.

Peer Review Stage

1. The Editorial Board forwards the manuscript to the Head of the Specialty Section to invite two independent reviewers with relevant expertise.
2. Reviewers evaluate the manuscript and provide one of the following recommendations:
• Accept as submitted
• Accept with minor revisions
• Accept with major revisions
• Revise and resubmit for further review
• Reject

In cases where reviewer recommendations are inconsistent (e.g., one reviewer recommends acceptance after revision while the other recommends rejection), a third reviewer will be invited to provide an additional assessment. The final decision is made based on the collective evaluations.

The peer-review period typically lasts 4 to 6 weeks from the date the manuscript is sent to reviewers.

Handling of review process

1. Acceptance without revision: The Editorial Office proceeds with the publication process.
2. Acceptance with revisions: Authors are requested to revise the manuscript according to reviewer comments. The revision period ranges from 2 to 3 weeks from the date authors receive the notification. This revision cycle may be repeated up to two times per manuscript, if necessary. Once reviewer approval is obtained, the manuscript proceeds to publication.
3. Rejection: Manuscripts that fail to meet quality standards and are not recommended for publication by both reviewers will be rejected.

Publication

1. The Editorial Office compiles all accepted and revised manuscripts and submits them to the Editorial Board for final evaluation. The Editor-in-Chief makes the final publication decision based on the following criteria:
• Relevance to the Journal’s aims and scope
• Article type (priority given to in-depth, high-quality original research)
• Scientific contribution and novelty
• Priority for publication in the nearest issue, based on topical relevance, manuscript quality, and submission date

Each issue publishes no more than two articles per corresponding author (i.e., first author).

1. The Editorial Board and Editorial Office conduct copyediting, layout formatting, and proofreading.
2. The Editorial Office notifies authors via email regarding the final decision, publication schedule, issue number, and volume.
3. The list of published articles for each issue is officially announced and made publicly available on the Journal’s website at https://tapchi.ctump.edu.vn.

Article Processing Charges (APC)

• Submission fee: 1,500,000 VND per article (approximately 57 USD).
• Authors who are staff members of Can Tho University of Medicine and Pharmacy are eligible for a 50% reduction in the submission fee.
• Undergraduate students conducting university-level research projects are eligible for a 100% waiver of the publication fee (authors must attach the official decision approving the student research project).

Payment methods:

              Bank transfer:
              Account Name: Can Tho University of Medicine and Pharmacy
              Account Number: 0111000115668
              Bank: Vietcombank – Can Tho Branch

Effective date: January 1, 2025.

Submission fees are non-refundable in cases of rejection or manuscript withdrawal.

Manuscripts must be submitted via the Journal’s online system at:
https://tapchi.ctump.edu.vn